An improved whole cell pertussis vaccine with reduced content of endotoxin
Open Access
- 1 February 2013
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 9 (2) , 339-348
Abstract
An improved whole cell pertussis vaccine, designated as Plow, which is low in endotoxicity due to a chemical extraction of lipo-oligosaccharide (LOS) from the outer membrane, was evaluated for safe...Keywords
This publication has 38 references indexed in Scilit:
- Global, regional, and national causes of child mortality in 2008: a systematic analysisThe Lancet, 2010
- Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in miceVaccine, 2009
- Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in InfantsClinical and Vaccine Immunology, 2009
- Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type bMemórias do Instituto Oswaldo Cruz, 2008
- Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxesGenome Biology, 2007
- Lipopolysaccharide Analogs Improve Efficacy of Acellular Pertussis Vaccine and Reduce Type I Hypersensitivity in MiceClinical and Vaccine Immunology, 2007
- Expression of the Lipopolysaccharide-Modifying Enzymes PagP and PagL Modulates the Endotoxic Activity ofBordetella pertussisInfection and Immunity, 2006
- Live Attenuated B. pertussis as a Single-Dose Nasal Vaccine against Whooping CoughPLOS Pathogens, 2006
- Comparison of the rabbit pyrogen test and Limulus amoebocyte lysate (LAL) assay for endotoxin in hepatitis B vaccines and the effect of aluminum hydroxideBiologicals, 2005
- Pertussis resurgence in Canada largely caused by a cohort effectThe Pediatric Infectious Disease Journal, 2003